SYNLOGIC, INC. (SYBX) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Dec 03, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for SYNLOGIC, INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, SYNLOGIC, INC.'s filing signal continuing negative.
earningsVibe SuperAnalyst™ Verdict: CONTINUING NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+4.17%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does SYNLOGIC, INC. actually do?
Answer:
Synlogic, Inc. is a biopharmaceutical company that has ceased active drug development and is now focused on pursuing strategic initiatives, including a potential merger or sale, to enhance stockholder value. Previously, the company focused on rare metabolic disorders, with lead programs in phenylketonuria (PKU) and homocystinuria (HCU). However, in February 2024, Synlogic discontinued its pivotal Phase 3 study for PKU due to the trial being unlikely to meet its primary endpoint. Consequently, the company has significantly reduced its operations, with only one full-time employee remaining as of March 2026, and its shares have been delisted from Nasdaq and are now traded on the OTC Markets. Its intellectual property portfolio includes over 114 Synlogic-owned patents and patent applications.
Question:
What are SYNLOGIC, INC.'s revenue drivers?
Answer:
The company has not generated product revenue and previously had revenue from a material transfer and consulting agreement that concluded in March 2024. Its current strategy is focused on strategic transactions rather than revenue generation from operations.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required